Lena Niehoff | Taylor Wessing

Lena is a litigation lawyer specialising in product liability and the life sciences sector. She advises companies on out-of-court dispute resolution and represents them before state courts or arbitration tribunals. She has particular experience in advising and representing pharmaceutical and medtech companies.

Lena specialises in disputes between companies in connection with purchasing, development, production and distribution. She is also an expert in product liability and product safety issues and has many years of experience in representing companies in product liability proceedings, including the defence of class actions.

CV

Since 2024 Salary Partner, Taylor Wessing

2022 - 2024 Senior Associate, Taylor Wessing

2018 - 2022 Associate, Taylor Wessing

Career

Since 2024 Salary Partner, Taylor Wessing

2022 - 2024 Senior Associate, Taylor Wessing

2018 - 2022 Associate, Taylor Wessing

Education

2020 Doctoral degree in law, University of Passau

2018 Admitted as a lawyer, Frankfurt am Main

2015 – 2017 Second State Examination, Higher Regional Court Frankfurt am Main, including training in Tokyo

Publications

Neues Produkthaftungsgesetz in Sicht, ZRP 2026, 14 (beck-online)

Niehoff/Moelle, Neues Produkthaftungsgesetz 2026 – Referentenentwurf zur Umsetzung der EU Produkthaftungsrichtlinie liegt vor, PHi 2025, 207

Lexology In-Depth: Product Regulation and Liability, European Union Chapter

Niehoff/Moelle, MPR 2024, 35 ff., Zur Frage eines Produktfehlers bei einem Bruch einer Hüftendoprothese, Anm. zu BGH, Urteil from 1 August 2023, VI ZR 82/22

German Chapter in Chambers Global Practical Guide Product Liability & Safety 2023, together with Dr. Henning Moelle, Dr. Philipp Behrendt and Donata von Enzberg

Marke verpflichtet – zur Produkthaftung der Markeninhaberin, ECJ judgment of July 7, 2022 – C-264/21, in: Deutscher AnwaltSpiegel, Issue 24, 2022

Additional languages

Awards

The Best Lawyers™ in Germany 2025

Featured

Experience

COVID-19 vaccine product liability proceedings

Representing AstraZeneca in all product liability proceedings relating to its COVID-19 vaccine in Germany.

Dr. Henning Moelle, LL.M.

Dr. Lena Niehoff

Florian Lambracht

David Hilger, LL.M. (Bilbao)

Lena's news & insights

View Lena's insights

Click here to find out more

Life sciences & healthcare

Insights from Member States: What can we expect from the new Product Liability Directive?

17 July 2025

by multiple authors

Synapse - Post market activities including PMS and product liability

A new era for product liability in the EU

This article outlines the key changes introduced by the new PLD. It explores the expanded scope of liability and the broader pool of potentially liable parties, as well as the new rules on the burden of proof and disclosure of evidence.

17 July 2025

Briefing

by multiple authors

1 of 6 Insights

Click here to find out more

Synapse - AI in Life Sciences

New product liability risks for AI products

The new Product Liability Directive aims to modernise the product liability rules and remove obstacles for consumers. What should life sciences companies using AI in products know about the new product liability rules.

6 March 2025

by Dr. Lena Niehoff

5 of 10 Insights

Click here to find out more

Dr. Lena Niehoff

The Best Lawyers™ in Germany 2025

Expertise

Services and Groups

Sectors